Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 13Sanofi

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : USA

LIXISENATIDE

Brand Name : ADLYXIN

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 0.15MG/3ML (0.05MG/ML)

Packaging :

Approval Date :

Application Number : 208471

Regulatory Info :

Registration Country : USA

Sanofi Company Banner

02

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : USA

LIXISENATIDE

Brand Name : ADLYXIN

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 0.3MG/3ML (0.1MG/ML)

Packaging :

Approval Date :

Application Number : 208471

Regulatory Info :

Registration Country : USA

Sanofi Company Banner

03

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : USA

INSULIN GLARGINE; LIXISENATIDE

Brand Name : SOLIQUA 100/33

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 300 UNITS/3ML;99MCG/3ML (100 UNITS/ML;33MCG/ML)

Packaging :

Approval Date :

Application Number : 208673

Regulatory Info :

Registration Country : USA

Sanofi Company Banner

04

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Sweden

lixisenatid

Brand Name : Lyxumia

Dosage Form : SOLUTION FOR INJECTION IN PRE-FILLED

Dosage Strength : 10 MICROGRAMS / DOSE

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Sanofi Company Banner

05

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Sweden

lixisenatid

Brand Name : Lyxumia

Dosage Form : SOLUTION FOR INJECTION IN PRE-FILLED

Dosage Strength : 20 MICROGRAMS / DOSE

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Sanofi Company Banner

06

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Sweden

lixisenatid

Brand Name : Lyxumia

Dosage Form : SOLUTION FOR INJECTION IN PRE-FILLED

Dosage Strength : 10 MICROGRAMS

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Sanofi Company Banner

07

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Italy

Lixisenatide

Brand Name : Lyxumia

Dosage Form : Lixisenatide 10Mcg 3Ml 1 Units Parenteral Use

Dosage Strength : 1 cartridge SC in preriemp pen 3 ml 10 mcg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

08

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Italy

Lixisenatide

Brand Name : Lyxumia

Dosage Form : Lixisenatide 20Mcg 3Ml 2 Units Parenteral Use

Dosage Strength : 2 cartridges SC in preriemp pen 3 ml 20 mcg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

09

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Italy

Lixisenatide

Brand Name : Lyxumia

Dosage Form : Lixisenatide 10Mcg+20Mcg 3Ml 1+1 Units Parenteral Use

Dosage Strength : 1 cartridge SC in preriemp pen 3 ml 10 mcg + 1 cartridge SC in preriemp pen 3 ml 20 mcg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

10

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Norway

Lixisenatide

Brand Name : Lyxumia

Dosage Form : Injection fluid, resolution

Dosage Strength : 10 mcg

Packaging : Finish filled pen

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Sanofi Company Banner

11

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Norway

Lixisenatide

Brand Name : Lyxumia

Dosage Form : Injection fluid, resolution

Dosage Strength : 20 mcg

Packaging : Finish filled pen

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Sanofi Company Banner

12

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Norway

Lixisenatide

Brand Name : Lyxumia Boot Gasket

Dosage Form :

Dosage Strength :

Packaging : Finish filled pen

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Sanofi Company Banner

13

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Prescription

Registration Country : Canada

LIXISENATIDE

Brand Name : SOLIQUA

Dosage Form : SOLUTION

Dosage Strength : 33MCG/ML

Packaging :

Approval Date :

Application Number : 2478293

Regulatory Info : Prescription

Registration Country : Canada

Sanofi Company Banner